Table 2 Distribution of histological classification and gender in patients with T2DM and lung cancer
Histological classifications | Age | Gender | Total | Proportion | |||
|---|---|---|---|---|---|---|---|
Male | Female | ||||||
Adenocarcinoma | 66.74 ± 8.17 | 256 | 62.29% | 155 | 37.71% | 411 | 60.62% |
Squamous carcinoma | 65.89 ± 8.27 | 61 | 64.89% | 33 | 35.11% | 94 | 13.86% |
Small cell carcinoma | 65.80 ± 7.05 | 15 | 60.00% | 10 | 40.00% | 25 | 3.69% |
Mixed carcinoma | 66.20 ± 6.75 | 8 | 80.00% | 2 | 20.00% | 10 | 1.47% |
Neuroendocrine carcinoma | 67.17 ± 7.49 | 4 | 66.67% | 2 | 33.33% | 6 | 0.88% |
Magnocellular carcinoma | 69.00 ± 5.66 | 2 | 100.00% | 0 | 0.00% | 2 | 0.29% |
Other | 68.67 ± 7.15 | 6 | 100.00% | 0 | 0.00% | 6 | 0.88% |
Unknown | 67.05 ± 9.57 | 96 | 77.42% | 28 | 22.58% | 124 | 18.29% |
Total | 66.66 ± 8.36 | 448 | 66.08% | 230 | 33.92% | 678 | 100.00% |